Nontypeable Haemophilus influenzae susceptibility: Effect of inoculum size and β-lactamase production
- 31 October 1996
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 26 (2) , 95-98
- https://doi.org/10.1016/s0732-8893(96)00182-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A survey of β-lactamase-producing Haemophilus influenzae an evaluation of 5750 isolatesDiagnostic Microbiology and Infectious Disease, 1995
- In-vitro evaluation of cefpodoximeJournal of Antimicrobial Chemotherapy, 1994
- Invasive Haemophilus influenzae infections in men with HIV infectionPublished by American Medical Association (AMA) ,1992
- Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzaeAntimicrobial Agents and Chemotherapy, 1991
- Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United StatesAntimicrobial Agents and Chemotherapy, 1990
- In-vitro activities of trospectomycin, cefpodoxime, and second-generation cephalosporins against Haemophilus influenzae type bJournal of Antimicrobial Chemotherapy, 1989
- Inoculum EffectClinical Infectious Diseases, 1989
- Antibacterial activities of cefpodoxime, cefixime, and ceftriaxoneAntimicrobial Agents and Chemotherapy, 1988
- Prevalence of antimicrobial resistance among clinical isolates ofHaemophilus influenzaeDiagnostic Microbiology and Infectious Disease, 1986
- Nontypable Haemophilus influenzae (Biotype 4) as a Neonatal, Maternal, and Genital PathogenClinical Infectious Diseases, 1983